Loading stock data…
NBP
$2.38-0.09 (-3.64%)
Market ClosedLast close May 1
NovaBridge Biosciences, a biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
NovaBridge Biosciences in the Healthcare sector is trading at $2.38. The stock is currently 65% below its 52-week high of $6.79, remaining 35.3% below its 200-day moving average. Technical signals show neutral RSI of 49 and bullish MACD crossover, explaining why NBP maintains its current current market pressure. The Whystock Score of 15/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 49) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$2.38
Potential Upside
5%
Whystock Fair Value$2.50
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
NovaBridge Biosciences, a biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States. The company is developing givastomig, a bispecific antibody, which is in Phase 1b clinical trial for the...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$286.69M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.74
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-996.76%
Volume
Today's trading volume
1.85M
Recent News
Amazon downgraded, Roblox upgraded: Wall Street's top analyst calls
Amazon downgraded, Roblox upgraded: Wall Street's top analyst calls
Insider Spends US$5.1m Buying More Shares In NovaBridge Biosciences
NovaBridge Biosciences ( NASDAQ:NBP ) shareholders (or potential shareholders) will be happy to see that the Executive...
Is There An Opportunity With NovaBridge Biosciences' (NASDAQ:NBP) 40% Undervaluation?
Key Insights The projected fair value for NovaBridge Biosciences is US$6.70 based on 2 Stage Free Cash Flow to Equity...
Companies Like NovaBridge Biosciences (NASDAQ:NBP) Can Afford To Invest In Growth
Just because a business does not make any money, does not mean that the stock will go down. By way of example...